We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FRST:NASDAQPrimis Financial Corp. Analysis

Data as of 2026-06-16 - not real-time

$15.45

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Primis Financial Corp. (FRST) is trading at $15.45, comfortably above its 20‑day SMA of $14.79 and 50‑day SMA of $14.43, indicating a short‑term bullish bias. The RSI sits at 63, well below overbought levels, while the MACD histogram remains positive, reinforcing momentum. Price action respects a clear support zone near $13.80 and faces resistance around $15.89, offering a modest upside of roughly 13% per the computed upside/downside metric. Volatility over the past 30 days is elevated at ~24.8%, yet the beta of 0.68 suggests the stock moves less than the broader market, tempering systematic risk. Fundamentally, the stock appears undervalued with a trailing PE of 8.3 versus an industry average of 17.1, and a price‑to‑book below 1.0, highlighting a discount to book value. The dividend yield of 2.61% is supported by a low payout ratio of 21%, making the dividend sustainable. However, revenue has contracted by 22.7% year‑over‑year and operating cash flow is negative, signaling earnings pressure. The company’s market cap of ~$383 M and stable volume profile provide adequate liquidity, while the “Extreme Greed” sentiment on the fear‑greed index reflects strong investor appetite. Overall, the blend of bullish technicals, attractive valuation, and a solid dividend offsets the near‑term earnings headwinds.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (price above SMA, positive MACD)
  • Support level at $13.80 providing downside cushion
  • Sustainable dividend with low payout ratio

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Undervalued valuation metrics (low PE, P/B < 1)
  • Continuing revenue decline and negative operating cash flow
  • Attractive dividend yield supporting total return

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Persistent earnings pressure from shrinking loan and deposit volumes
  • Potential regulatory headwinds in the regional banking sector
  • Dividend sustainability and value‑oriented pricing

Key Metrics & Analysis

Financial Health

Revenue Growth-22.70%
Profit Margin23.25%
P/E Ratio8.3
ROE11.49%
ROA1.16%
P/B Ratio0.9
Op. Cash Flow$-77988000
Industry P/E17.1

Technical Analysis

TrendBullish
RSI63.4
Support$13.80
Resistance$15.89
MA 20$14.79
MA 50$14.43
MA 200$12.73
MACDBullish
VolumeStable
Fear & Greed Index92.13

Valuation

Target Price$17.50
Upside/Downside13.27%
GradeUndervalued
TypeValue
Dividend Yield2.61%

Risk Assessment

Beta0.68
Volatility24.81%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.